{"topic_id":"evidence_canine_urolith_struvite_diet","category":"evidence","context":"---\ntopic_id: evidence_canine_urolith_struvite_diet\ncategory: evidence\ntitle: Evidence cluster — dietary management of struvite uroliths in dogs (peer-reviewed, Europe PMC + PubMed)\nlang: en\nsource_file: pdf-raw/evidence/europepmc_canine_urolith_struvite_diet_2026-07-22.txt\nsource: Europe PMC REST search (first-hand PMIDs) + PubMed efetch verbatim abstracts, pulled 2026-07-22\ndate_parsed: 2026-07-22\nmodel: codebuddy\nbatch: P0-EVIDENCE-6\nverified: true\npath: evidence/evidence_canine_urolith_struvite_diet/01_canine_urolith_struvite_diet.md\nsource_document: \"Veterinary / medical evidence (guideline or study) — PMID 41742526\"\ncitation:\n  authority: \"Europe PMC\"\n  title: \"Evidence cluster — dietary management of struvite uroliths in dogs (peer-reviewed, Europe PMC + PubMed)\"\n  url: \"https://pubmed.ncbi.nlm.nih.gov/41742526/\"\n  retrieved: \"2026-07-22\"\n  ref: \"PMID 41742526\"\n  doc_type: \"official PDF\"\n  needs_review: false\nlicense: cc_by\nauthority_tier: T2\nauthority_tier_basis: \"T2:oa-repo\"\nauthority_tier_date: 2026-08-04\n---\n# evidence_canine_urolith_struvite_diet\n\nSource: first-hand peer-reviewed abstracts (Europe PMC / PubMed efetch), reproduced verbatim. Each claim below is a C1 substring of the cited source file.\n\n## Claims (C1 — verbatim substrings of source_file)\n\n1. PMID 41742526 — Outcomes of medical dissolution for suspected struvite uroliths in dogs using a therapeutic multipurpose urinary diet and antimicrobial therapy (J Vet Intern Med, 2026). Abstract (opening): BACKGROUND: The consensus recommendation is to medically dissolve suspected struvite uroliths in dogs. However, more data is needed on outcomes for protocols using therapeutic multipurpose urinary foods formulated for both struvite urolith dissolution and calcium oxalate urolith prevention.\n2. PMID 41001835 — In Vivo Radiographic Characteristics Associated With the Mineral Composition of Calcium Oxalate, Struvite, and Cystine Lower Urinary Tract Uroliths in Dogs (J Vet Intern Med, 2025). Abstract (opening): BACKGROUND: Identifying urolith mineral composition (UMC) is crucial for treatment and prevention; however, current data rely on macroscopic or ex vivo studies.\n3. PMID 40293168 — Association of Diet and Calcium Tartrate Tetrahydrate Uroliths in Dogs (J Vet Intern Med, 2025). Abstract (opening): BACKGROUND: Calcium tartrate tetrahydrate (CTT) uroliths are recently identified in dogs. OBJECTIVES: To report on the types and prevalence of diets, supplements, and medications containing salts of tartaric acid consumed by dogs with CTT urolithiasis.\n4. PMID 39368059 — Medical dissolution of presumptive upper urinary tract struvite uroliths in 6 dogs (2012-2018) (J Vet Intern Med, 2024). Abstract (opening): BACKGROUND: Minimally invasive approaches are the standard for treatment of upper urinary tract uroliths in humans. OBJECTIVE: To describe the medical dissolution of upper urinary tract uroliths in a series of dogs and report clinical outcomes.\n5. PMID 41630760 — Comprehensive diagnostic evaluation of urolithiasis and cystitis in K9 dogs in Iraq: Clinical, laboratory, and imaging correlates (Open Vet J, 2025). Abstract (opening): BACKGROUND: Urolithiasis and cystitis are major contributors to urinary tract morbidity in dogs, particularly in working K9 units. Due to overlapping symptoms, proper differentiation is crucial.\n6. PMID 40104003 — Retrospective study of 353 confirmed cases of urolithiasis in dogs and cats treated at veterinary clinics in the northern region of Pará, Brazil (Braz J Vet Med, 2025). Abstract (opening): Urolithiasis is the third most prevalent disease of the urinary tract of dogs and cats, and is characterized by presence of crystals and / or formation of stones. The present study objective was to report the confirmation rate of suspected cases of urolithiasis in dogs and cats treated at veterinary clinics in the city of Santarém, Pará.\n\nSource: `pdf-raw/evidence/europepmc_canine_urolith_struvite_diet_2026-07-22.txt`\n\n## License & attribution\n\nSource abstracts / records are Open Access under Creative Commons. Each referenced\nstudy is reproduced with attribution under its specific CC license (CC BY / CC BY-NC /\nCC BY-NC-ND); the exact license variant for each reference is stated on its Europe PMC /\nPMC record. Original records:\n- https://pubmed.ncbi.nlm.nih.gov/39368059/\n- https://pubmed.ncbi.nlm.nih.gov/40104003/\n- https://pubmed.ncbi.nlm.nih.gov/40293168/\n- https://pubmed.ncbi.nlm.nih.gov/41001835/\n- https://pubmed.ncbi.nlm.nih.gov/41630760/\n- https://pubmed.ncbi.nlm.nih.gov/41742526/\n","sources":["Europe PMC — Evidence cluster — dietary management of struvite uroliths in dogs (peer-reviewed, Europe PMC + PubMed) (retrieved 2026-07-22)"],"source":{"authority":"Europe PMC","title":"Evidence cluster — dietary management of struvite uroliths in dogs (peer-reviewed, Europe PMC + PubMed)","url":"https://pubmed.ncbi.nlm.nih.gov/41742526/","retrieved":"2026-07-22","ref":"PMID 41742526","doc_type":"official PDF","source_document":"Veterinary / medical evidence (guideline or study) — PMID 41742526","verification_file":"pdf-raw/evidence/europepmc_canine_urolith_struvite_diet_2026-07-22.txt"},"source_document":"Veterinary / medical evidence (guideline or study) — PMID 41742526","source_file":"pdf-raw/evidence/europepmc_canine_urolith_struvite_diet_2026-07-22.txt","trust":{"authority_tier":"T2","fidelity":"verbatim","license":"cc_by","display_grade":"A"},"tokens_estimated":756,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}